Arkema SA (OTCMKTS:ARKAY) Receives Consensus Recommendation of “Reduce” from Brokerages

Arkema SA (OTCMKTS:ARKAY) has been given an average recommendation of “Reduce” by the eight research firms that are presently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and two have assigned a buy recommendation to the company.

ARKAY has been the subject of a number of recent research reports. Kepler Capital Markets downgraded Arkema from a “strong-buy” rating to a “hold” rating in a report on Friday, February 27th. The Goldman Sachs Group raised Arkema from a “hold” rating to a “buy” rating in a report on Tuesday, February 10th. Finally, Zacks Research lowered Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, January 6th.

Arkema Trading Up 1.8%

ARKAY opened at $64.85 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 2.13 and a quick ratio of 2.26. Arkema has a fifty-two week low of $56.28 and a fifty-two week high of $79.68. The company’s 50 day moving average price is $65.79 and its two-hundred day moving average price is $62.96. The firm has a market capitalization of $4.93 billion, a price-to-earnings ratio of 74.54, a PEG ratio of 1.56 and a beta of 0.87.

About Arkema

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.